HUMANA INC 8-K

What Happened

• Humana Inc. filed an 8‑K on April 20, 2026 reporting the results of its Annual Meeting held April 16, 2026. Holders of 107,941,773 shares were present by proxy, constituting a quorum.
• All ten director nominees were elected. The meeting also ratified PricewaterhouseCoopers LLP as independent auditor, approved the non‑binding advisory vote on executive compensation, approved the Humana Inc. 2026 Stock Incentive Plan, and rejected a shareholder proposal to require shareholder approval for excessive golden parachutes.

Key Details

• Directors: All 10 nominees were elected. Vote totals for “For” ranged from 85,170,452 (Wayne A. I. Frederick, M.D.) to 101,367,406 (James A. Rechtin). Broker non‑votes for director elections: 5,739,045.
• Auditor ratification: PricewaterhouseCoopers LLP ratified as auditor for 2026 — 102,433,686 For, 5,381,161 Against, 126,926 Abstained.
• Executive compensation (advisory): Approved — 97,237,851 For, 4,669,732 Against, 295,145 Abstained; broker non‑votes: 5,739,045.
• Stock Incentive Plan: Approved — 97,655,200 For, 4,295,549 Against, 251,979 Abstained; broker non‑votes: 5,739,045.
• Shareholder proposal on golden parachutes: Not approved — 41,970,892 For, 59,079,279 Against, 1,152,557 Abstained; broker non‑votes: 5,739,045.

Why It Matters

• Board continuity: Election of all ten nominees means Humana’s current board slate and governance team remain in place for the coming year, which matters for strategic oversight and risk management.
• Auditor and governance votes: Ratification of PwC and approval of the advisory executive compensation vote and the 2026 Stock Incentive Plan clear key governance and compensation matters that affect financial reporting and executive pay programs.
• Shareholder influence: The defeat of the golden‑parachute shareholder proposal indicates investors did not support a new shareholder approval requirement for certain severance/pay practices, signaling limited immediate change to existing change‑in‑control pay policies.